ReviewCureus2026
Potential Adjunctive Role of Osteopathic Manipulative Medicine in the Management of Cancer-Related Bone Pain: A Narrative Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteopathic manipulative medicine (OMM) is known for its therapeutic potential on the musculoskeletal system, and its emerging role and potential benefits in oncology care are gaining attention. Patients with primary and metastatic bone cancer tend to experience pain, restricted movement, and lower quality of life due to the pathology and its treatment. This narrative review examines the mechanistic rationale and available clinical evidence supporting the use of OMM in the management of pain and functional impairment among patients with bone malignancies. A literature search was conducted using PubMed and Google Scholar to identify peer-reviewed studies published between 2005 and 2025 addressing OMM interventions in oncologic and bone cancer populations. Relevant clinical and mechanistic studies were synthesized to evaluate potential therapeutic roles and safety considerations. Limited clinical studies suggest that select OMM techniques, including myofascial release (MFR), gentle soft tissue methods, and lymphatic approaches, may contribute to improvements in pain perception, mobility, and fatigue in oncology populations. Evidence specific to primary bone malignancies remains sparse, with most data derived from small trials, observational studies, and extrapolation from broader cancer cohorts. OMM may offer a non-pharmacologic adjunct targeting biomechanical dysfunction, autonomic regulation, and lymphatic flow, which are implicated in cancer-related pain and functional decline. However, heterogeneity in study design, small sample sizes, and limited bone-specific data constrain definitive conclusions. Current evidence suggests that OMM has potential as a supportive modality in bone cancer care, particularly for symptom management and functional rehabilitation. Rigorous, well-designed clinical trials are needed to establish safety parameters, standardized protocols, and efficacy within this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.